Trials / Completed
CompletedNCT01039506
An Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic Colorectal Cancer (mCRC)
A Prospective Observational Study of the Efficacy and Safety of CPT-11 Based Regimens for UGT1A1 Genotype Guided Patients With Metastatic Colorectal Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,376 (actual)
- Sponsor
- Daiichi Sankyo Co., Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the correlation between UGT1A1 genotypes and the efficacy of CPT-11 based regimens (FOLFIRI, CPT-11+S-1, CPT-11) for patients with metastatic colorectal cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CPT-11 based regimens |
Timeline
- Start date
- 2009-10-15
- Primary completion
- 2016-04-28
- Completion
- 2016-07-01
- First posted
- 2009-12-25
- Last updated
- 2019-05-29
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01039506. Inclusion in this directory is not an endorsement.